- Presentations
- 5
- Markets
- 1
Zemplar is a brand of Paricalcitol marketed by AbbVie, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Paricalcitol
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 1 mcg capsule, 2 mcg capsule, 10 mcg/2 mL injection, 2 mcg/1 mL injection, 5 mcg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Zemplar 1 mcg capsuleOral | AbbVie | US FDA | Available on request |
| Zemplar 2 mcg capsuleOral | AbbVie | US FDA | Available on request |
| Zemplar 10 mcg/2 mL injectionIntravenous | AbbVie | US FDA | Available on request |
| Zemplar 2 mcg/1 mL injectionIntravenous | AbbVie | US FDA | Available on request |
| Zemplar 5 mcg/1 mL injectionIntravenous | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Zemplar
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.